By transactivation of miR-34a, p53 was recently shown to repress the expression of programmed cell death-ligand 1 (PD-L1), which is overexpressed in many human cancers, promoting T-cell tolerance and escaping host immunity [53]. Here, CD274 is linked to cancer.